En bref :
Join us at the WIN 2019 symposium on 23-24 June, 2019 in Paris, France.
Innovation and worldwide deployment of Precision Oncology were the aspirational goals of Dr. John Mendelsohn, founder and chairman of WIN and Prof. Waun Ki Hong, special advisor to WIN for lung cancer. In their honour, WIN will continue the work started by these two great giants in oncology and work to achieve rapid and efficient translation of ground-breaking early diagnostic and personalized cancer medicine discoveries into the standards for clinical care, to significantly improve the outcomes and quality of life of cancer patients worldwide.
WIN 2019 has gathered renowned experts across the world including Jennifer A. Doudna, co-inventor of the gene-editing technology, CRISPR/Cas9, who will present a talk on this "crack in creation" and the complex ethics of genetic manipulation. Other speakers will be Jennifer A. Ligibel, Razelle Kurzrock, Apostolia-Maria Tsimberidou, Christophe Le Tourneau, Phillip G. Febbo, Andrew Mortlock and Jean-François Martini and many others, who will discuss both the latest discoveries as well as the real world experience of Precision Oncology.
Join the conversation online with the #winsympo2019 hashtag.
on Sunday June 23, 2019 at 9:30 am (ends Monday June 24, 2019 at 5:00 pm)
